Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayano Nishinoiri

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Heliyon|February 14, 2024
Albumin-fused thioredoxin ameliorates high-fat diet-induced non-alcoholic steatohepatitisRyota Murata, Hiroshi Watanabe, Ryotaro Iwakiri, et al.
Endocrinology|January 15, 2026
α1-Acid Glycoprotein Mitigates MASLD Progression by Modulating Liver and Adipose Tissue FunctionAyano Nishinoiri, Kai Tokumaru, Gai Kanazawa, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 23, 2023
Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver diseaseMayuko Chikamatsu, Hiroshi Watanabe, Yuhi Shintani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2025
Secreted protein acidic and rich in cysteine-guided biomimetic delivery of nano-antioxidants reverses muscle atrophy in a mouse model of sarcopeniaGai Kanazawa, Hitoshi Maeda, Kengo Yasuda, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Heliyon|February 14, 2024
Albumin-fused thioredoxin ameliorates high-fat diet-induced non-alcoholic steatohepatitisRyota Murata, Hiroshi Watanabe, Ryotaro Iwakiri, et al.
Endocrinology|January 15, 2026
α1-Acid Glycoprotein Mitigates MASLD Progression by Modulating Liver and Adipose Tissue FunctionAyano Nishinoiri, Kai Tokumaru, Gai Kanazawa, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 23, 2023
Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver diseaseMayuko Chikamatsu, Hiroshi Watanabe, Yuhi Shintani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2025
Secreted protein acidic and rich in cysteine-guided biomimetic delivery of nano-antioxidants reverses muscle atrophy in a mouse model of sarcopeniaGai Kanazawa, Hitoshi Maeda, Kengo Yasuda, et al.
Pageof 1